Published in Arch Gen Psychiatry on May 01, 2002
The neurocircuitry of fear, stress, and anxiety disorders. Neuropsychopharmacology (2010) 4.82
Targeting abnormal neural circuits in mood and anxiety disorders: from the laboratory to the clinic. Nat Neurosci (2007) 4.46
Effects of mindfulness-based stress reduction (MBSR) on emotion regulation in social anxiety disorder. Emotion (2010) 3.23
Neural bases of social anxiety disorder: emotional reactivity and cognitive regulation during social and physical threat. Arch Gen Psychiatry (2009) 2.37
Uncertainty and anticipation in anxiety: an integrated neurobiological and psychological perspective. Nat Rev Neurosci (2013) 2.23
Oxytocin attenuates amygdala reactivity to fear in generalized social anxiety disorder. Neuropsychopharmacology (2010) 1.98
Corticolimbic brain reactivity to social signals of threat before and after sertraline treatment in generalized social phobia. Biol Psychiatry (2012) 1.78
Neural mechanisms of cognitive reappraisal of negative self-beliefs in social anxiety disorder. Biol Psychiatry (2009) 1.72
Glucocorticoids reduce phobic fear in humans. Proc Natl Acad Sci U S A (2006) 1.64
The study of fear extinction: implications for anxiety disorders. Am J Psychiatry (2011) 1.60
Preventing excessive weight gain in adolescents: interpersonal psychotherapy for binge eating. Obesity (Silver Spring) (2007) 1.33
fMRI predictors of treatment outcome in pediatric anxiety disorders. Psychopharmacology (Berl) (2006) 1.30
Predicting treatment response in social anxiety disorder from functional magnetic resonance imaging. JAMA Psychiatry (2013) 1.29
Neural systems underlying approach and avoidance in anxiety disorders. Dialogues Clin Neurosci (2010) 1.27
Symptom provocation and reduction in patients suffering from spider phobia: an fMRI study on exposure therapy. Eur Arch Psychiatry Clin Neurosci (2007) 1.26
Amygdala and insula response to emotional images in patients with generalized social anxiety disorder. J Psychiatry Neurosci (2009) 1.25
Single photon emission computed tomography (SPECT) of anxiety disorders before and after treatment with citalopram. BMC Psychiatry (2004) 1.08
Impact of cognitive behavioral therapy for social anxiety disorder on the neural dynamics of cognitive reappraisal of negative self-beliefs: randomized clinical trial. JAMA Psychiatry (2013) 1.08
A neuropsychiatric model of biological and psychological processes in the remission of delusions and auditory hallucinations. Schizophr Bull (2006) 1.07
Neural predictors and mechanisms of cognitive behavioral therapy on threat processing in social anxiety disorder. Prog Neuropsychopharmacol Biol Psychiatry (2013) 1.07
Reduced amygdalar and hippocampal size in adults with generalized social phobia. J Psychiatry Neurosci (2010) 1.00
Neuroimaging in psychiatry: from bench to bedside. Front Hum Neurosci (2009) 0.96
Relationships among cognition, emotion, and motivation: implications for intervention and neuroplasticity in psychopathology. Front Hum Neurosci (2013) 0.95
Chronic antidepressant treatment impairs the acquisition of fear extinction. Biol Psychiatry (2012) 0.93
How to boost positive interpretations? A meta-analysis of the effectiveness of cognitive bias modification for interpretation. PLoS One (2014) 0.93
Neural changes following cognitive behaviour therapy for psychosis: a longitudinal study. Brain (2011) 0.92
Neural correlates of psychotherapy in anxiety and depression: a meta-analysis. PLoS One (2013) 0.91
Brain imaging and psychotherapy: methodological considerations and practical implications. Eur Arch Psychiatry Clin Neurosci (2008) 0.90
Altered fusiform connectivity during processing of fearful faces in social anxiety disorder. Transl Psychiatry (2013) 0.90
Increased neural habituation in the amygdala and orbitofrontal cortex in social anxiety disorder revealed by FMRI. PLoS One (2012) 0.90
Does neuroimaging research examining the pathophysiology of posttraumatic stress disorder require medication-free patients? J Psychiatry Neurosci (2010) 0.90
Neurotrophic gene polymorphisms and response to psychological therapy. Transl Psychiatry (2012) 0.90
Neural changes with attention bias modification for anxiety: a randomized trial. Soc Cogn Affect Neurosci (2014) 0.89
Amygdala subregions tied to SSRI and placebo response in patients with social anxiety disorder. Neuropsychopharmacology (2012) 0.89
The pathophysiology of body dysmorphic disorder. Body Image (2008) 0.86
Predicting long-term outcome of Internet-delivered cognitive behavior therapy for social anxiety disorder using fMRI and support vector machine learning. Transl Psychiatry (2015) 0.86
Cognitive interventions targeting brain plasticity in the prodromal and early phases of schizophrenia. Annu Rev Clin Psychol (2013) 0.86
Neuroimaging in anxiety disorders. J Neural Transm (Vienna) (2008) 0.86
Classifying social anxiety disorder using multivoxel pattern analyses of brain function and structure. Behav Brain Res (2013) 0.84
The neurobiology of dispositional negativity and attentional biases to threat: Implications for understanding anxiety disorders in adults and youth. J Exp Psychopathol (2016) 0.83
Serotonin, Amygdala and Fear: Assembling the Puzzle. Front Neural Circuits (2016) 0.83
Attachment-security priming attenuates amygdala activation to social and linguistic threat. Soc Cogn Affect Neurosci (2014) 0.82
Neuroimaging predictors of treatment response in anxiety disorders. Biol Mood Anxiety Disord (2013) 0.81
Coping changes the brain. Front Behav Neurosci (2013) 0.81
Neuroimaging studies of pediatric social anxiety: paradigms, pitfalls and a new direction for investigating the neural mechanisms. Biol Mood Anxiety Disord (2013) 0.81
Functional neuroimaging studies of the effects of psychotherapy. Dialogues Clin Neurosci (2014) 0.81
Neural response to eye contact and paroxetine treatment in generalized social anxiety disorder. Psychiatry Res (2011) 0.81
The effect of doxapram on brain imaging in patients with panic disorder. Eur Neuropsychopharmacol (2007) 0.81
Impact of cognitive-behavioral therapy for social anxiety disorder on the neural bases of emotional reactivity to and regulation of social evaluation. Behav Res Ther (2014) 0.81
Intersubject variability in fearful face processing: the link between behavior and neural activation. Cogn Affect Behav Neurosci (2014) 0.80
Dispositional negativity: An integrative psychological and neurobiological perspective. Psychol Bull (2016) 0.79
Neuroimaging for psychotherapy research: current trends. Psychother Res (2014) 0.79
Disruption of Memory Reconsolidation Erases a Fear Memory Trace in the Human Amygdala: An 18-Month Follow-Up. PLoS One (2015) 0.79
Cognitive-behavioral therapy for generalized anxiety disorder is associated with attenuation of limbic activation to threat-related facial emotions. J Affect Disord (2014) 0.78
A pilot study of gray matter volume changes associated with paroxetine treatment and response in social anxiety disorder. Psychiatry Res (2015) 0.78
Body Dysmorphic Disorder: Neurobiological Features and an Updated Model. Z Klin Psychol Psychother (Gott) (2013) 0.78
Changes in dopamine D2-receptor binding are associated to symptom reduction after psychotherapy in social anxiety disorder. Transl Psychiatry (2012) 0.78
Association between amygdala reactivity and a dopamine transporter gene polymorphism. Transl Psychiatry (2014) 0.78
Area-dependent time courses of brain activation during video-induced symptom provocation in social anxiety disorder. Biol Mood Anxiety Disord (2014) 0.77
Targeted deletion of Vglut2 expression in the embryonal telencephalon promotes an anxiolytic phenotype of the adult mouse. Ups J Med Sci (2015) 0.77
Psychotherapy and brain plasticity. Front Psychol (2013) 0.77
The Interface between Neuroscience and Neuro-Psychoanalysis: Focus on Brain Connectivity. Front Hum Neurosci (2016) 0.76
Impact of pharmacological and psychological treatment methods of depressive and anxiety disorders on cognitive functioning. J Neural Transm (Vienna) (2014) 0.76
Altered time course of amygdala activation during speech anticipation in social anxiety disorder. J Affect Disord (2016) 0.75
Analysis of Altered Baseline Brain Activity in Drug-Naive Adult Patients with Social Anxiety Disorder Using Resting-State Functional MRI. Psychiatry Investig (2015) 0.75
Neuroplasticity in response to cognitive behavior therapy for social anxiety disorder. Transl Psychiatry (2016) 0.75
Neural Correlates of Outcome of the Psychotherapy Compared to Antidepressant Therapy in Anxiety and Depression Disorders: A Meta-Analysis. Front Psychol (2017) 0.75
Psychotherapy and Neuroimaging. Focus (Am Psychiatr Publ) (2014) 0.75
All in the mind? New molecular insights might bridge the gap between the effects of psychiatric therapy and drugs. EMBO Rep (2009) 0.75
Social anxiety disorder and the psychobiology of self-consciousness. Front Hum Neurosci (2015) 0.75
CBT reduces CBF: cognitive-behavioral therapy reduces cerebral blood flow in fear-relevant brain regions in spider phobia. Brain Behav (2016) 0.75
Pharmaco fMRI: Determining the functional anatomy of the effects of medication. Neuroimage Clin (2016) 0.75
Brain connectivity changes occurring following cognitive behavioural therapy for psychosis predict long-term recovery. Transl Psychiatry (2017) 0.75
Synthesis and Antimicrobial Screening of Novel 4-Substituted Phenyl-5-[1-(4-fluorophenyl)-1,3-dihydroisobenzofuran-5-yl]-2H-1,2,4-triazole-3-thiones. Int Sch Res Notices (2014) 0.75
Cognitive behavioural therapy attenuates the enhanced early facial stimuli processing in social anxiety disorders: an ERP investigation. Behav Brain Funct (2017) 0.75
Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B. Ann Neurol (2004) 21.56
Two-year follow-up of amyloid deposition in patients with Alzheimer's disease. Brain (2006) 5.42
PET imaging of amyloid deposition in patients with mild cognitive impairment. Neurobiol Aging (2007) 4.47
A meta-analysis of heart rate variability and neuroimaging studies: implications for heart rate variability as a marker of stress and health. Neurosci Biobehav Rev (2011) 3.21
Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up. Hepatology (2015) 2.81
The use of PET in Alzheimer disease. Nat Rev Neurol (2010) 2.13
Neuropeptide Y5 receptor antagonism does not induce clinically meaningful weight loss in overweight and obese adults. Cell Metab (2006) 2.02
Low PiB PET retention in presence of pathologic CSF biomarkers in Arctic APP mutation carriers. Neurology (2012) 2.02
Rapid bone and blood flow formation in impacted morselized allografts: positron emission tomography (PET) studies on allografts in 5 femoral component revisions of total hip arthroplasty. Acta Orthop Scand (2003) 1.82
Positron emission tomography microdosing: a new concept with application in tracer and early clinical drug development. Eur J Clin Pharmacol (2003) 1.65
Long-term survival according to ventilation mode in acute respiratory failure secondary to chronic obstructive pulmonary disease: a multicenter, inception cohort study. J Crit Care (2010) 1.60
Chronic whiplash symptoms are related to altered regional cerebral blood flow in the resting state. Eur J Pain (2008) 1.55
Probiotics in prevention of IgE-associated eczema: a double-blind, randomized, placebo-controlled trial. J Allergy Clin Immunol (2007) 1.55
Disruption of reconsolidation erases a fear memory trace in the human amygdala. Science (2012) 1.51
Guided and unguided self-help for social anxiety disorder: randomised controlled trial. Br J Psychiatry (2009) 1.50
Species differences in blood-brain barrier transport of three positron emission tomography radioligands with emphasis on P-glycoprotein transport. Drug Metab Dispos (2008) 1.50
Effect of phenserine treatment on brain functional activity and amyloid in Alzheimer's disease. Ann Neurol (2008) 1.50
Association between admission supine systolic blood pressure and 1-year mortality in patients admitted to the intensive care unit for acute chest pain. JAMA (2010) 1.49
A link between serotonin-related gene polymorphisms, amygdala activity, and placebo-induced relief from social anxiety. J Neurosci (2008) 1.47
Serotonin transporter polymorphism related to amygdala excitability and symptom severity in patients with social phobia. Neurosci Lett (2004) 1.47
Sensed presence and mystical experiences are predicted by suggestibility, not by the application of transcranial weak complex magnetic fields. Neurosci Lett (2005) 1.40
GMP--three letters with many interpretations. Protection of patients or killing the clinical and research applications of PET? Eur J Nucl Med Mol Imaging (2008) 1.39
Ventilation distribution studies comparing Technegas and "Gallgas" using 68GaCl3 as the label. J Nucl Med (2011) 1.39
The Q705K polymorphism in NLRP3 is a gain-of-function alteration leading to excessive interleukin-1β and IL-18 production. PLoS One (2012) 1.36
A twin study of the genetics of fear conditioning. Arch Gen Psychiatry (2003) 1.30
In vivo amyloid imaging with PET in frontotemporal dementia. Eur J Nucl Med Mol Imaging (2007) 1.29
Human positron emission tomography studies of brain neurokinin 1 receptor occupancy by aprepitant. Biol Psychiatry (2004) 1.28
Combined polymorphisms in genes encoding the inflammasome components NALP3 and CARD8 confer susceptibility to Crohn's disease in Swedish men. Am J Gastroenterol (2009) 1.26
Time trends in STEMI--improved treatment and outcome but still a gender gap: a prospective observational cohort study from the SWEDEHEART register. BMJ Open (2012) 1.26
18F-ML-10, a PET tracer for apoptosis: first human study. J Nucl Med (2011) 1.26
Cerebral blood flow during anticipation of public speaking in social phobia: a PET study. Biol Psychiatry (2002) 1.24
Dynamic changes in PET amyloid and FDG imaging at different stages of Alzheimer's disease. Neurobiol Aging (2010) 1.24
Cerebral blood flow changes after treatment of social phobia with the neurokinin-1 antagonist GR205171, citalopram, or placebo. Biol Psychiatry (2005) 1.23
A European multicentre PET study of fibrillar amyloid in Alzheimer's disease. Eur J Nucl Med Mol Imaging (2012) 1.21
Evidence for astrocytosis in prodromal Alzheimer disease provided by 11C-deuterium-L-deprenyl: a multitracer PET paradigm combining 11C-Pittsburgh compound B and 18F-FDG. J Nucl Med (2012) 1.19
Amygdala and anterior cingulate cortex activation during affective startle modulation: a PET study of fear. Eur J Neurosci (2003) 1.18
Neurofunctional correlates of posttraumatic stress disorder: a PET symptom provocation study. Eur Arch Psychiatry Clin Neurosci (2002) 1.18
Neural correlates of training-related working-memory gains in old age. Neuroimage (2011) 1.18
PET in the diagnosis of neuroendocrine tumors. Ann N Y Acad Sci (2004) 1.17
Duration and degree of cyclosporin induced P-glycoprotein inhibition in the rat blood-brain barrier can be studied with PET. Neuroimage (2006) 1.17
Preparation and evaluation of (68)Ga-DOTA-hEGF for visualization of EGFR expression in malignant tumors. J Nucl Med (2005) 1.16
PET imaging of cortical 11C-nicotine binding correlates with the cognitive function of attention in Alzheimer's disease. Psychopharmacology (Berl) (2006) 1.15
Inflammasome polymorphisms confer susceptibility to sporadic malignant melanoma. Pigment Cell Melanoma Res (2012) 1.13
In vivo binding of [68Ga]-DOTATOC to somatostatin receptors in neuroendocrine tumours--impact of peptide mass. Nucl Med Biol (2010) 1.12
[11C]metomidate positron emission tomography of adrenocortical tumors in correlation with histopathological findings. J Clin Endocrinol Metab (2006) 1.11
[(11)C]PIB-amyloid binding and levels of Abeta40 and Abeta42 in postmortem brain tissue from Alzheimer patients. Neurochem Int (2008) 1.11
Activation in striatum and medial temporal lobe during sequence learning in younger and older adults: relations to performance. Neuroimage (2010) 1.10
The role of PET in localization of neuroendocrine and adrenocortical tumors. Ann N Y Acad Sci (2002) 1.09
In vivo visualization of amyloid deposits in the heart with 11C-PIB and PET. J Nucl Med (2012) 1.09
Dopamine D(1) receptors and age differences in brain activation during working memory. Neurobiol Aging (2009) 1.09
Imaging the pathology of Alzheimer's disease: amyloid-imaging with positron emission tomography. Neuroimaging Clin N Am (2003) 1.07
Neural mechanisms of reading facial emotions in young and older adults. Front Psychol (2012) 1.05
Brain regions involved in fatigue sensation: reduced acetylcarnitine uptake into the brain. Neuroimage (2002) 1.05
Disentangling the web of fear: amygdala reactivity and functional connectivity in spider and snake phobia. Psychiatry Res (2009) 1.04
Restricted cortical and amygdaloid removal of vesicular glutamate transporter 2 in preadolescent mice impacts dopaminergic activity and neuronal circuitry of higher brain function. J Neurosci (2009) 1.04
The prognostic value of the Modified Early Warning Score in critically ill patients: a prospective, observational study. Eur J Anaesthesiol (2012) 1.01
Differential levels of apolipoprotein E and butyrylcholinesterase show strong association with pathological signs of Alzheimer's disease in the brain in vivo. Neurobiol Aging (2010) 1.01
A gender perspective on short- and long term mortality in ST-elevation myocardial infarction--a report from the SWEDEHEART register. Int J Cardiol (2012) 1.00
Association between ulcerative growth and hypoxia inducible factor-1alpha polymorphisms in colorectal cancer patients. Mol Carcinog (2006) 1.00
Pharmacokinetics and red cell utilization of 52Fe/59Fe-labelled iron polymaltose in anaemic patients using positron emission tomography. Br J Haematol (2003) 0.99
Unidirectional Influx and Net Accumulation of PIB. Open Neuroimag J (2008) 0.98
Imaging of peptide adsorption to microfluidic channels in a plastic compact disc using a positron emitting radionuclide. Lab Chip (2005) 0.98
Noise correlation in PET, CT, SPECT and PET/CT data evaluated using autocorrelation function: a phantom study on data, reconstructed using FBP and OSEM. BMC Med Imaging (2005) 0.98
Bone regeneration 6 years after impaction bone grafting: a PET analysis. Acta Orthop (2007) 0.98
Immobility--a major risk factor for development of pressure ulcers among adult hospitalized patients: a prospective study. Scand J Caring Sci (2004) 0.98
Imaging the placebo response: a neurofunctional review. Eur Neuropsychopharmacol (2008) 0.97
Cerebral blood flow and metabolism after cardiopulmonary resuscitation. A pathophysiologic and prognostic positron emission tomography pilot study. Resuscitation (2003) 0.97
Symptom provocation in specific phobia affects the substance P neurokinin-1 receptor system. Biol Psychiatry (2006) 0.97
Neuroticism-related personality traits are related to symptom severity in patients with premenstrual dysphoric disorder and to the serotonin transporter gene-linked polymorphism 5-HTTPLPR. Arch Womens Ment Health (2010) 0.96
Acupuncture improves health-related quality-of-life (HRQoL) and sleep in women with breast cancer and hot flushes. Support Care Cancer (2011) 0.96
Radical carbonylation with [11C]carbon monoxide promoted by oxygen-centered radicals: experimental and DFT studies of the mechanism. J Am Chem Soc (2007) 0.95
Biodistribution of 68Ga-labelled phosphodiester, phosphorothioate, and 2'-O-methyl phosphodiester oligonucleotides in normal rats. Eur J Pharm Sci (2005) 0.95
Glucose metabolism and PIB binding in carriers of a His163Tyr presenilin 1 mutation. Neurobiol Aging (2009) 0.95
[(11)C] Carbon monoxide in selenium-mediated synthesis of (11)C-carbamoyl compounds. J Org Chem (2002) 0.95
Enhanced amygdala responses to emotional versus neutral schematic facial expressions. Neuroreport (2002) 0.94
Increased response-time variability is associated with reduced inferior parietal activation during episodic recognition in aging. J Cogn Neurosci (2008) 0.94
Genotype over-diagnosis in amygdala responsiveness: affective processing in social anxiety disorder. J Psychiatry Neurosci (2009) 0.94
Imaging of aromatase distribution in rat and rhesus monkey brains with [11C]vorozole. Nucl Med Biol (2006) 0.93
High-frequency heart rate variability and cortico-striatal activity in men and women with social phobia. Neuroimage (2009) 0.92
Multitracer study with positron emission tomography in Creutzfeldt-Jakob disease. Eur J Nucl Med Mol Imaging (2002) 0.92
Social phobia in Swedish adolescents : prevalence and gender differences. Soc Psychiatry Psychiatr Epidemiol (2008) 0.92
Leukemia in childhood and adolescence and exposure to ionizing radiation in homes built from uranium-containing alum shale concrete. Epidemiology (2002) 0.92
Age effects to negative arousal differ for self-report and electrodermal activity. Psychophysiology (2007) 0.91